Skip to content

Semaglutide clinical trials: 210 trials

Page 4 of 5

  1. Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

    NCT07092605 · Early phase 1 · Enrolling by invitation

    Linked paper with results

  2. Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

    NCT01686945 · Phase 1 · Completed

    Linked paper with results

  3. A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes

    NCT04032197 · Phase 1 · Completed

    Linked paper with results

  4. A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

    NCT03600480 · Phase 1 · Completed

    Linked paper with results

  5. A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes

    NCT02212067 · Phase 1 · Completed

    Linked paper with results

  6. A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

    NCT03842202 · Phase 1 · Completed

    Linked paper with results

  7. Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function

    NCT02014259 · Phase 1 · Completed

    Linked paper with results

  8. A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver

    NCT03357380 · Phase 1 · Completed

    Linked paper with results

  9. Effect of Renal Impairment on the Pharmacokinetics of NN9535

    NCT00833716 · Phase 1 · Completed

    Linked paper with results

  10. A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity

    NCT05236517 · Phase 1 · Completed

    Linked paper with results

  11. Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment

    NCT02016911 · Phase 1 · Completed

    Linked paper with results

  12. Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

    NCT02249871 · Phase 1 · Completed

    Linked paper with results

  13. A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

    NCT02070510 · Phase 1 · Completed

    Linked paper with results

  14. A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects

    NCT02146079 · Phase 1 · Completed

    Linked paper with results

  15. Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

    NCT02210871 · Phase 1 · Completed

    Linked paper with results

  16. A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects

    NCT03010475 · Phase 1 · Completed

    Linked paper with results

  17. A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes

    NCT02147431 · Phase 1 · Completed

    Linked paper with results

  18. A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

    NCT03288740 · Phase 1 · Completed

    Linked paper with results

  19. A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese

    NCT04016974 · Phase 1 · Completed

    Linked paper with results

  20. Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects

    NCT02249910 · Phase 1 · Completed

    Linked paper with results

  21. Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects

    NCT02243098 · Phase 1 · Completed

    Linked paper with results

  22. A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together

    NCT03789578 · Phase 1 · Completed

    Linked paper with results

  23. Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo

    NCT02079870 · Phase 1 · Completed

    Linked paper with results

  24. A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

    NCT02845219 · Phase 1 · Completed

    Linked paper with results

  25. Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

    NCT02022254 · Phase 1 · Completed

    Linked paper with results

  26. A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes

    NCT02773381 · Phase 1 · Completed

    Linked paper with results

  27. Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

    NCT07223983 · Phase 1 · Active, not recruiting

    Linked paper with results

  28. Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

    NCT05768945 · Phase not stated · Completed

    Posted results

  29. Body Surface Gastric Mapping in Patients on Semaglutide

    NCT06401746 · Phase not stated · Completed

    Posted results

  30. Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

    NCT07096063 · Phase not stated · Completed

    Linked paper with results

  31. Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

    NCT06659744 · Phase not stated · Completed

    Linked paper with results

  32. Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

    NCT06779929 · Phase not stated · Completed

    Linked paper with results

  33. Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

    NCT06914102 · Phase not stated · Completed

    Linked paper with results

  34. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World

    NCT06874751 · Phase not stated · Completed

    Linked paper with results

  35. Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

    NCT06914141 · Phase not stated · Completed

    Linked paper with results

  36. Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels

    NCT07043361 · Phase not stated · Completed

    Linked paper with results

  37. Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data

    NCT05577728 · Phase not stated · Completed

    Linked paper with results

  38. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)

    NCT04261933 · Phase not stated · Completed

    Linked paper with results

  39. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

    NCT04094415 · Phase not stated · Completed

    Linked paper with results

  40. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

    NCT04083820 · Phase not stated · Completed

    Linked paper with results

  41. Comprehensive Clinical Evaluation Study of GLP-1RA

    NCT06686134 · Phase not stated · Recruiting

    Linked paper with results

  42. A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice

    NCT05443334 · Phase not stated · Completed

    Linked paper with results

  43. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

    NCT03457012 · Phase not stated · Completed

    Linked paper with results

  44. A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice

    NCT04862923 · Phase not stated · Completed

    Linked paper with results

  45. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)

    NCT03648281 · Phase not stated · Completed

    Linked paper with results

  46. Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

    NCT07309094 · Phase not stated · Recruiting

    Linked paper with results

  47. Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

    NCT07653412 · Phase not stated · Recruiting

    Linked paper with results

  48. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)

    NCT03929679 · Phase not stated · Completed

    Linked paper with results

  49. A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)

    NCT03631186 · Phase not stated · Completed

    Linked paper with results

  50. Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

    NCT07621419 · Phase not stated · Recruiting

    Linked paper with results

How PepBank reports evidence